Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study

Standard

Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study. / Ali, Farihah; Kaura, Ashima; Russell, Cayley; Bonn, Matthew; Bruneau, Julie; Dasgupta, Nabarun; Imtiaz, Sameer; Martel-Laferrière, Valérie; Rehm, Jürgen; Shahin, Rita; Elton-Marshall, Tara.

In: HARM REDUCT J, Vol. 20, No. 1, 29.07.2023, p. 99.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Ali, F, Kaura, A, Russell, C, Bonn, M, Bruneau, J, Dasgupta, N, Imtiaz, S, Martel-Laferrière, V, Rehm, J, Shahin, R & Elton-Marshall, T 2023, 'Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study', HARM REDUCT J, vol. 20, no. 1, pp. 99. https://doi.org/10.1186/s12954-023-00826-6

APA

Ali, F., Kaura, A., Russell, C., Bonn, M., Bruneau, J., Dasgupta, N., Imtiaz, S., Martel-Laferrière, V., Rehm, J., Shahin, R., & Elton-Marshall, T. (2023). Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study. HARM REDUCT J, 20(1), 99. https://doi.org/10.1186/s12954-023-00826-6

Vancouver

Bibtex

@article{2f04e8b2b3bb478eafc6e7a1d8b90f14,
title = "Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study",
abstract = "BACKGROUND: People Who Use Drugs (PWUD) have lower vaccination uptake than the general population, and disproportionately experience the burden of harms from vaccine-preventable diseases. We conducted a national qualitative study to: (1) identify the barriers and facilitators to receiving COVID-19 vaccinations among PWUD; and (2) identify interventions to support PWUD in their decision-making.METHODS: Between March and October 2022, semi-structured interviews with PWUD across Canada were conducted. Fully vaccinated (2 or more doses) and partially or unvaccinated (1 dose or less) participants were recruited from a convenience sample to participate in telephone interviews to discuss facilitators, barriers, and concerns about receiving COVID-19 vaccines and subsequent boosters, and ways to address concerns. A total of 78 PWUD participated in the study, with 50 participants being fully vaccinated and 28 participants partially or unvaccinated. Using thematic analysis, interviews were coded based on the capability, opportunity, and motivation-behavior (COM-B) framework.RESULTS: Many partially or unvaccinated participants reported lacking knowledge about the COVID-19 vaccine, particularly in terms of its usefulness and benefits. Some participants reported lacking knowledge around potential long-term side effects of the vaccine, and the differences of the various vaccine brands. Distrust toward government and healthcare agencies, the unprecedented rapidity of vaccine development and skepticism of vaccine effectiveness were also noted as barriers. Facilitators for vaccination included a desire to protect oneself or others and compliance with government mandates which required individuals to get vaccinated in order to access services, attend work or travel. To improve vaccination uptake, the most trusted and appropriate avenues for vaccination information sharing were identified by participants to be people with lived and living experience with drug use (PWLLE), harm reduction workers, or healthcare providers working within settings commonly visited by PWUD.CONCLUSION: PWLLE should be supported to design tailored information to reduce barriers and address mistrust. Resources addressing knowledge gaps should be disseminated in areas and through organizations where PWUD frequently access, such as harm reduction services and social media platforms.",
keywords = "Humans, COVID-19 Vaccines, COVID-19/prevention & control, Vaccination, Canada, Government",
author = "Farihah Ali and Ashima Kaura and Cayley Russell and Matthew Bonn and Julie Bruneau and Nabarun Dasgupta and Sameer Imtiaz and Val{\'e}rie Martel-Laferri{\`e}re and J{\"u}rgen Rehm and Rita Shahin and Tara Elton-Marshall",
note = "{\textcopyright} 2023. The Author(s).",
year = "2023",
month = jul,
day = "29",
doi = "10.1186/s12954-023-00826-6",
language = "English",
volume = "20",
pages = "99",
journal = "HARM REDUCT J",
issn = "1477-7517",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study

AU - Ali, Farihah

AU - Kaura, Ashima

AU - Russell, Cayley

AU - Bonn, Matthew

AU - Bruneau, Julie

AU - Dasgupta, Nabarun

AU - Imtiaz, Sameer

AU - Martel-Laferrière, Valérie

AU - Rehm, Jürgen

AU - Shahin, Rita

AU - Elton-Marshall, Tara

N1 - © 2023. The Author(s).

PY - 2023/7/29

Y1 - 2023/7/29

N2 - BACKGROUND: People Who Use Drugs (PWUD) have lower vaccination uptake than the general population, and disproportionately experience the burden of harms from vaccine-preventable diseases. We conducted a national qualitative study to: (1) identify the barriers and facilitators to receiving COVID-19 vaccinations among PWUD; and (2) identify interventions to support PWUD in their decision-making.METHODS: Between March and October 2022, semi-structured interviews with PWUD across Canada were conducted. Fully vaccinated (2 or more doses) and partially or unvaccinated (1 dose or less) participants were recruited from a convenience sample to participate in telephone interviews to discuss facilitators, barriers, and concerns about receiving COVID-19 vaccines and subsequent boosters, and ways to address concerns. A total of 78 PWUD participated in the study, with 50 participants being fully vaccinated and 28 participants partially or unvaccinated. Using thematic analysis, interviews were coded based on the capability, opportunity, and motivation-behavior (COM-B) framework.RESULTS: Many partially or unvaccinated participants reported lacking knowledge about the COVID-19 vaccine, particularly in terms of its usefulness and benefits. Some participants reported lacking knowledge around potential long-term side effects of the vaccine, and the differences of the various vaccine brands. Distrust toward government and healthcare agencies, the unprecedented rapidity of vaccine development and skepticism of vaccine effectiveness were also noted as barriers. Facilitators for vaccination included a desire to protect oneself or others and compliance with government mandates which required individuals to get vaccinated in order to access services, attend work or travel. To improve vaccination uptake, the most trusted and appropriate avenues for vaccination information sharing were identified by participants to be people with lived and living experience with drug use (PWLLE), harm reduction workers, or healthcare providers working within settings commonly visited by PWUD.CONCLUSION: PWLLE should be supported to design tailored information to reduce barriers and address mistrust. Resources addressing knowledge gaps should be disseminated in areas and through organizations where PWUD frequently access, such as harm reduction services and social media platforms.

AB - BACKGROUND: People Who Use Drugs (PWUD) have lower vaccination uptake than the general population, and disproportionately experience the burden of harms from vaccine-preventable diseases. We conducted a national qualitative study to: (1) identify the barriers and facilitators to receiving COVID-19 vaccinations among PWUD; and (2) identify interventions to support PWUD in their decision-making.METHODS: Between March and October 2022, semi-structured interviews with PWUD across Canada were conducted. Fully vaccinated (2 or more doses) and partially or unvaccinated (1 dose or less) participants were recruited from a convenience sample to participate in telephone interviews to discuss facilitators, barriers, and concerns about receiving COVID-19 vaccines and subsequent boosters, and ways to address concerns. A total of 78 PWUD participated in the study, with 50 participants being fully vaccinated and 28 participants partially or unvaccinated. Using thematic analysis, interviews were coded based on the capability, opportunity, and motivation-behavior (COM-B) framework.RESULTS: Many partially or unvaccinated participants reported lacking knowledge about the COVID-19 vaccine, particularly in terms of its usefulness and benefits. Some participants reported lacking knowledge around potential long-term side effects of the vaccine, and the differences of the various vaccine brands. Distrust toward government and healthcare agencies, the unprecedented rapidity of vaccine development and skepticism of vaccine effectiveness were also noted as barriers. Facilitators for vaccination included a desire to protect oneself or others and compliance with government mandates which required individuals to get vaccinated in order to access services, attend work or travel. To improve vaccination uptake, the most trusted and appropriate avenues for vaccination information sharing were identified by participants to be people with lived and living experience with drug use (PWLLE), harm reduction workers, or healthcare providers working within settings commonly visited by PWUD.CONCLUSION: PWLLE should be supported to design tailored information to reduce barriers and address mistrust. Resources addressing knowledge gaps should be disseminated in areas and through organizations where PWUD frequently access, such as harm reduction services and social media platforms.

KW - Humans

KW - COVID-19 Vaccines

KW - COVID-19/prevention & control

KW - Vaccination

KW - Canada

KW - Government

U2 - 10.1186/s12954-023-00826-6

DO - 10.1186/s12954-023-00826-6

M3 - SCORING: Journal article

C2 - 37516836

VL - 20

SP - 99

JO - HARM REDUCT J

JF - HARM REDUCT J

SN - 1477-7517

IS - 1

ER -